Physician profile
Cindy Lang
NPI 1083349161
$3,218.65
in general payments reported to CMS, 2019-2025
14 companies · $470 in 2025
The $470 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,070 · 2024: $1,678 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,902 · Travel and Lodging: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,901.71 |
| Travel and Lodging | $316.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $713.21 | 2023-2025 | Total30, Precision 7, Precision7 |
| Biotissue Holdings INC. | $711.65 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $353.34 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $264.38 | 2023-2024 | Ce-Marked Kxla System |
| Harrow Eye, LLC | $216.23 | 2024-2025 | Vevye |
| Bausch & Lomb Americas INC. | $185.26 | 2023-2025 | Xiidra, Miebo |
| Lumenis Be INC | $168.50 | 2023 | Optilight |
| Oyster Point Pharma, INC. | $140.92 | 2023 | Tyrvaya |
| Abbvie INC. | $138.92 | 2023 | |
| Coopervision INC. | $90.98 | 2025 | Misight Contact Lens |
| Lkc Technologies, INC. | $88.85 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $84.10 | 2023-2024 | Acuvue, Axert |
| Dompe US, INC. | $44.26 | 2024 | Oxervate |
| Sun Pharmaceutical Industries INC. | $18.05 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.